Moderna and Merck’s cancer vaccine reduced the risk of melanoma recurrence or death by 42%, but investors questioned its ...

“This is the first step,” said Dr. Robert Vonderheide, president-elect of the American Association for Cancer Research and ...

A first-of-its-kind vaccine against cancer may be on the horizon.

The authorisation covers Iceland, Liechtenstein, Norway, and all 27 EU member states.

Merck's Courtney Ronaldo discusses the strategy behind the company's new oncology campaign, its multichannel presence at ESMO ...

I hope future Camels will continue to enjoy and benefit from this space for many years to come.” Made possible with generous ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...

Brain cancer remains one of the hardest cancers to treat, and researchers are under pressure to find therapies that do more than slow the disease for a short time. For patients with aggressive tumors ...

Follow Fox News’ live coverage of the 2026 midterm elections as Trump campaigns in Iowa, Democrats challenge election ...

The Marjorie Luke Theatre’s Green Film Series explores a hidden environmental disaster off the Southern California coast, followed by a discussion with environmental experts ...

Merck’s Keytruda plus Padcev receives European Commission approval to treat adults with resectable muscle-invasive bladder cancer: Rahway, New Jersey Friday, October 23, 2026, 1 ...

Msd announced today that the European Commission has approved pembrolizumab in combination with enfortumab vedotin, as neoadjuvant treatment and subsequently, after radical cystectomy, as adjuvant ...